Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
300
0.25 ug per day for one year
one pill per day
Taixing People's Hospital
Taishing, Jiangsu, China
Osteoprotegin level
To assess the effect of vitamin D supplementation on osteoprotegin level in CKD patients
Time frame: one year
Bone mineral density
To assess the effect of vitamin D supplementation on bone mineral density in patients with CKD stage 1 and 2
Time frame: one year
vascular calcification score
To assess the effect of vitamin D supplementation on vascular calcification score through performing lateral abdominal radiography or CT-based techniques in patients with CKD stage 1 and 2
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.